Advertisement
News
Subscribe to MDT Magazine News

Aushon in research deal with Peking University Cancer Hospital

February 8, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Microarray and immunoassay company Aushon BioSystems Inc. of Billerica said it has signed a diagnostic development collaboration letter of intent with Peking University Cancer Hospital (PUCH) in Beijing.

Pervasis hemodialysis treatment lands FDA fast-track review

February 8, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

The U.S. Food and Drug Administration has granted fast track review status to Cambridge biotech Pervasis Therapeutics Inc. for Vascugel, its lead drug program, a prevention treatment of kidney dialysis access failure in patients with end stage renal disease.

Rib-X moves skin infection treatment to Phase 2b trial

February 8, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Rib-X Pharmaceuticals Inc., an antibiotics company in New Haven, Conn., has begun a Phase 2b clinical trial of its treatments for acute bacterial skin and skin structure infections (ABSSSI).

Advertisement

Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience

February 8, 2011 9:37 am | by Bio-Medicine.Org | Comments

DALLAS, Feb. 8, 2011 /- Targetbase , a leading U.S.-based direct marketing agency known for its expertise in understanding consumer data, translating that data into intelligence, and using it to produce effective creative with measurable results, today announced that Peter Dannenfelser...

TOPICS:

New FDLI's Food and Drug Policy Forum Focuses on Liability Issues in Vaccine Design Defect Claims

February 8, 2011 9:37 am | by Bio-Medicine.Org | Comments

WASHINGTON, Feb. 8, 2011 /PRNewswire-USNewswire/ -- The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States,...

TOPICS:

February 10 Town Hall Meeting to Explain DC's New Medical Marijuana Program

February 8, 2011 9:37 am | by Bio-Medicine.Org | Comments

WASHINGTON, Feb. 8, 2011 /PRNewswire-USNewswire/ -- The District of Columbia Patients Cooperative (DCPC), a taxable non-profit corporation that formed one year ago to provide high quality and affordable medical "marijuana" to qualifying DC patients will host a "Town Hall" meeting about...

TOPICS:

Optasia gets FDA clearance on spinal imaging analyzer

February 8, 2011 8:41 am | by Mass High Tech: The Journal of New England Technology | Comments

Radiological imaging software company Optasia Medical of Sudbury has received 510(k) clearance from the U.S. Food and Drug Administration to market its SpineAnalyzer systems in the U.S.

TOPICS:

Late nights can lead to higher risk of strokes and heart attacks(2)

February 8, 2011 8:41 am | by EurekAlert | Comments

(University of Warwick) New research from Warwick Medical School published today in the European Heart Journal shows that prolonged sleep deprivation and disrupted sleep patterns can be linked to strokes, heart attacks and cardiovascular disorders which often result in early death.

TOPICS:
Advertisement

Late nights can lead to higher risk of strokes and heart attacks

February 8, 2011 8:40 am | Comments

University of Warwick

New silicon photonics foundry

February 8, 2011 7:37 am | by I-Micronews | Comments

Intel-backed OpSIS officially kicked off on February 1, and is now looking for partners and to recruit staff interested in silicon photonics.

BMW, PSA Peugeot Citroën team on electric components

February 8, 2011 7:37 am | by I-Micronews | Comments

European car manufacturers BMW and PSA Peugeot Citroën have set up a JV company called BMW Peugeot Citroën Electrification to work on the development of hybrid electric vehicle components, including power electronics and software.

New Gerngross startup Arsanis raises $9.6M

February 8, 2011 7:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Biotech startup Arsanis Inc. of Lebanon, N.H., has raised $9.6 million in a new round of funding, according to federal documents. Arsanis is another creation of Tillman Gerngross and Errik Anderson, both of Lebanon's Adimab Inc.

GlowCap maker Vitality bought by Soon-Shiong

February 8, 2011 7:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Vitality Inc., the Cambridge maker of the GlowCap pill packaging system, has been acquired by Patrick Soon-Shiong, a Los Angeles pharmaceuticals industry veteran, for an undisclosed amount.

MRI Medical Inc. Changing Name to Xeridiem Medical Devices, Inc.

February 8, 2011 7:35 am | by Bio-Medicine.Org | Comments

TUCSON, Ariz., Feb. 8, 2011 /- MRI Medical Inc. is changing its name to Xeridiem Medical Devices, Inc. as part of its corporate development plan. "Although we're changing our name, we will continue to provide our customers with the same superior design, development, and manufacturing...

TOPICS:

FDA Launches Medical Device Innovation Initiative

February 8, 2011 7:34 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Feb. 8, 2011 /PRNewswire-USNewswire/ --Today the U.S. Food and Drug Administration proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices and announced the first submission: a brain-controlled, upper-extremity prosthetic that...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading